Can ulcerative colitis be cured?
- PMID: 31361982
Can ulcerative colitis be cured?
Abstract
Ulcerative colitis is a life-long, chronic, relapsing and remitting inflammatory disease of the large intestine with an unpredictable course characterized by debilitating gastrointestinal symptoms accompanied by healthcare and emotional burdens that reduce the quality of life and the ability to work, attend school, and be productive. Ulcerative colitis affects millions of people worldwide and is now considered a global disease. Although some form of primary immune abnormality is thought to underlie this illness, extensive laboratory research conducted since the mid-20th century has largely failed to definitively establish a primary antecedent immune abnormality in individuals with ulcerative colitis or their family members. An alternative approach employing a systems pathogenesis analysis has implicated a causal role for colonocyte-generated hydrogen peroxide in the pathogenesis of this illness. Significantly elevated levels of hydrogen peroxide in non-inflamed colonic mucosa have been demonstrated in individuals with ulcerative colitis, implying a build-up prior to the onset of inflammation and supporting a causal role for colonocyte hydrogen peroxide in the development of this disease. Hydrogen peroxide's unique properties of cell membrane permeability, long life, potent oxidizing potential, and the ability to attract white blood cells combine to promote oxidative disintegration of colonic epithelial tight junctional proteins while attracting white blood cells into the colonic epithelium, both of which lead to colonic inflammation and eventual ulcerative colitis.
Similar articles
-
Downregulation of serotonin reuptake transporter gene expression in healing colonic mucosa in presence of remaining low-grade inflammation in ulcerative colitis.J Gastroenterol Hepatol. 2016 Aug;31(8):1443-52. doi: 10.1111/jgh.13268. J Gastroenterol Hepatol. 2016. PMID: 26676714
-
Ulcerative colitis--a disease characterised by the abnormal colonic epithelial cell?Gut. 1988 Apr;29(4):516-21. doi: 10.1136/gut.29.4.516. Gut. 1988. PMID: 3371720 Free PMC article.
-
Effect of toll-like receptor 3 agonist poly I:C on intestinal mucosa and epithelial barrier function in mouse models of acute colitis.World J Gastroenterol. 2017 Feb 14;23(6):999-1009. doi: 10.3748/wjg.v23.i6.999. World J Gastroenterol. 2017. PMID: 28246473 Free PMC article.
-
Evidence-based pathogenesis and treatment of ulcerative colitis: A causal role for colonic epithelial hydrogen peroxide.World J Gastroenterol. 2022 Aug 21;28(31):4263-4298. doi: 10.3748/wjg.v28.i31.4263. World J Gastroenterol. 2022. PMID: 36159014 Free PMC article. Review.
-
Ion transport and epithelial barrier dysfunction in experimental models of ulcerative colitis.Am J Physiol Gastrointest Liver Physiol. 2025 Jun 1;328(6):G811-G830. doi: 10.1152/ajpgi.00204.2024. Epub 2025 Apr 4. Am J Physiol Gastrointest Liver Physiol. 2025. PMID: 40184259 Free PMC article. Review.
Cited by
-
Ileo-Anal Pouch Anastomosis and New Remedial Approaches for Ulcerative Colitis: A Review Article.Cureus. 2023 Jan 21;15(1):e34027. doi: 10.7759/cureus.34027. eCollection 2023 Jan. Cureus. 2023. PMID: 36814731 Free PMC article. Review.
-
Nutrition and Supplementation in Ulcerative Colitis.Nutrients. 2022 Jun 14;14(12):2469. doi: 10.3390/nu14122469. Nutrients. 2022. PMID: 35745199 Free PMC article. Review.
-
Exploration of the Mechanisms Underlying Yu's Enema Formula in Treating Ulcerative Colitis by Blocking the RhoA/ROCK Pathway based on Network Pharmacology, High-performance Liquid Chromatography Analysis, and Experimental Verification.Curr Pharm Des. 2024;30(14):1085-1102. doi: 10.2174/0113816128290586240315071044. Curr Pharm Des. 2024. PMID: 38523541
-
Efficacy and safety of moxibustion for ulcerative colitis: protocol for a systematic review and meta-analysis.BMJ Open. 2024 Mar 18;14(3):e078878. doi: 10.1136/bmjopen-2023-078878. BMJ Open. 2024. PMID: 38503422 Free PMC article.
-
Circular RNA_0001187 participates in the regulation of ulcerative colitis development via upregulating myeloid differentiation factor 88.Bioengineered. 2022 May;13(5):12863-12875. doi: 10.1080/21655979.2022.2077572. Bioengineered. 2022. PMID: 35609334 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical